View all cases
- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Claimants
- QIAGEN Sciences, LLCOperating co.
Representatives- Clemens Plassmann-Hogan Lovells International LLP
- Markus Kuczera-Hogan Lovells International LLP
- Chia C. Chuong-Hogan Lovells International LLP
- Carla Rothsupporting-Hoffmann Eitle
- Lars Hemsathsupporting-Hoffmann Eitle
Respondents- bioMérieux SAOperating co.
- bioMérieux Deutschland GmbHOperating co.
Representatives- Oliver Jan Jüngst-Bird & Bird LLP
- Annika L. Lückemann-Bird & Bird LLP
- Selina Schneider-Bird & Bird LLP
- Division
- Dusseldorf LD
- Judges
- Technology
- InstrumentsAnalysis of biological materials
- Language
- —
- First decided
- Jul 23, 2025
- EPO Opposition
- BiomérieuxAdmissible2018-12-27
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Dusseldorf LD | Locked |
| Judge Jule Schumacher | Locked |
At the UPC: QIAGEN Sciences, LLC (5 cases)·bioMérieux Group (12 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 4 other proceedings
UPC CFI 497/2025·UPC CFI 516/2025·UPC CFI 181/2025·UPC APP 27426/2025
Start a free trial to see how each one ended.
More cases: Dusseldorf LD·2025
Decisions
- 2025-07-23
Summary: The Düsseldorf Local Division issued a procedural order extending a time period under Rule 9.3 RoP in an infringement action. The order relates to the protection of confidential information contained in the defendants' statement of defence and supporting exhibits regarding peptides used by the defendants and related analyses.
Show the legal issues (2)
- Extension of time period under Rule 9.3 RoP
- Protection of confidential information under Rule 262A RoP
Documents
- 7D15E921912E7F75CB5D11028C19706B_en.pdf2025-07-23EN